CDW Corporation/ US12514G1085 /
31/05/2024 22:15:00 | Chg. +0.7800 | Volume | Bid13:34:53 | Demandez à13:34:53 | Capitalisation boursière | Dividende Y. | Rapport P/E |
---|---|---|---|---|---|---|---|
223.6200USD | +0.35% | 1.43 Mio. Chiffrre d'affaires: 194.82 Mio. |
210.2500Bid taille: 200 | 224.4300Ask la taille: 100 | 36.4 Mrd.USD | 1.07% | 27.27 |
GlobeNewswire
14:31
German American Bancorp, Inc. announces the sale of the assets of German American Insurance, Inc. to...
Newsfile Corp
14:30
GoGold Resources Inc. to Participate in THE Mining Investment Event of the North, Canada's Only Tier...
GlobeNewswire
14:30
Safety Shot, World’s First Beverage to Reduce Blood Alcohol Content, Announces Launch of New 4-Ounce...
GlobeNewswire
14:30
TIAN RUIXIANG Holdings Ltd Regains Compliance with Nasdaq Minimum Bid Price Requirement and Receives...
GlobeNewswire
14:30
electroCore, Inc. Announces $9.3 Million Registered Direct Offering and Concurrent Private Placement...
GlobeNewswire
14:30
Lantheus’ AI-Enabled aPROMISE Now Available on Siemens Healthineers’ syngo.via platform
GlobeNewswire
14:30
FDA Provides Feedback and Reaches Consensus on Nexalin’s Design for Planned Anxiety and Insomnia Cli...
GlobeNewswire
14:30
LIXTE Biotechnology Holdings Names Distinguished Oncologist Jan Schellens as Chief Medical Officer
GlobeNewswire
14:30
Qlik Signs Strategic Collaboration Agreement with AWS to Accelerate Enterprise AI Adoption
GlobeNewswire
14:20
Microbot Medical Has Received FDA Approval to Proceed with its Pivotal Human Clinical Trial
GlobeNewswire
14:15
Autonomix Announces Approval of Protocol Amendment by Ethics Committee Upon Completion of All Lead-I...
GlobeNewswire
14:14
AUROBAC THERAPEUTICS Presents its R&D Strategy & Pipeline and Announces New Development Program in P...
GlobeNewswire
14:10
Maris-Tech Receives New Order for $225,000 From a Military Drone Manufacturer for a Unique Solution ...
GlobeNewswire
14:07
Four Charlesbank Portfolio Companies Named to Newsweek’s “America’s Greatest Workplaces for Mental W...
GlobeNewswire
14:05
NKGen Biotech To Present Updated Phase 1 Data on SNK02 Allogeneic NK Cell Therapy in Solid Tumors at...
- La première page
- Retour
- 1
- 2
- 3
- 4
- Suivant
- La dernière page